Wells Fargo’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $128M | Sell |
|
|||||
2025
Q1 | $109M | Buy |
|
|||||
2024
Q4 | $94M | Sell |
|
|||||
2024
Q3 | $93.1M | Buy |
|
|||||
2024
Q2 | $149M | Buy |
|
|||||
2024
Q1 | $176M | Sell |
|
|||||
2023
Q4 | $163M | Sell |
|
|||||
2023
Q3 | $128M | Sell |
|
|||||
2023
Q2 | $195M | Buy |
|
|||||
2023
Q1 | $167M | Sell |
|
|||||
2022
Q4 | $169M | Sell |
|
|||||
2022
Q3 | $121M | Sell |
|
|||||
2022
Q2 | $121M | Sell |
|
|||||
2022
Q1 | $235M | Buy |
|
|||||
2021
Q4 | $226M | Sell |
|
|||||
2021
Q3 | $546M | Sell |
|
|||||
2021
Q2 | $440M | Sell |
|
|||||
2021
Q1 | $397M | Buy |
|
|||||
2020
Q4 | $374M | Buy |
|
|||||
2020
Q3 | $399M | Sell |
|
|||||
2020
Q2 | $413M | Sell |
|
|||||
2020
Q1 | $382M | Sell |
|
|||||
2019
Q4 | $330M | Sell |
|
|||||
2019
Q3 | $255M | Buy |
|
|||||
2019
Q2 | $199M | Buy |
|
|||||
2019
Q1 | $81M | Sell |
|
|||||
2018
Q4 | $82.6M | Buy |
|
|||||
2018
Q3 | $94.6M | Buy |
|
|||||
2018
Q2 | $5.91M | Sell |
|
|||||
2018
Q1 | $5.64M | Sell |
|
|||||
2017
Q4 | $7.35M | Sell |
|
|||||
2017
Q3 | $13.9M | Sell |
|
|||||
2017
Q2 | $61.8M | Sell |
|
|||||
2017
Q1 | $76.7M | Sell |
|
|||||
2016
Q4 | $85.8M | Buy |
|
|||||
2016
Q3 | $125M | Sell |
|
|||||
2016
Q2 | $177M | Buy |
|
|||||
2016
Q1 | $87.5M | Sell |
|
|||||
2015
Q4 | $120M | Sell |
|
|||||
2015
Q3 | $131M | Sell |
|
|||||
2015
Q2 | $159M | Sell |
|
|||||
2015
Q1 | $141M | Sell |
|
|||||
2014
Q4 | $131M | Sell |
|
|||||
2014
Q3 | $99.9M | Buy |
|
|||||
2014
Q2 | $57.5M | Sell |
|
|||||
2014
Q1 | $70.7M | Buy |
|
|||||
2013
Q4 | $56.9M | Sell |
|
|||||
2013
Q3 | $48.9M | Sell |
|
|||||
2013
Q2 | $39.2M | Buy |
|